Cargando…
Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma
SIMPLE SUMMARY: Multiple myeloma (MM) patients with relapsing and/or refractory (RR) disease are exposed for a prolonged time to multiple drugs, which increase the risk of toxicity. In addition to tumor response, preserving the quality of life represents an important goal for this patient population...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508369/ https://www.ncbi.nlm.nih.gov/pubmed/34638462 http://dx.doi.org/10.3390/cancers13194978 |